Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Vertex's Non-opioid Drug Succeeds in Back Pain Trial
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Vertex Pharmaceuticals Announced Results From Its Phase 2 Study Of Suzetrigine For Painful Lumbosacral Radiculopathy, The Study Met Its Primary Endpoint With Statistically Significant And Clinically Meaningful Reduction In Pain On The Numeric Pain...
Biggest Stock Movers Thursday: MU, MESO, and More
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Trending Industry Today: Beam Therapeutics Leads Losses In Gene Editing Stocks
Amp : There is nothing negative about the deal. They have cash and opportunities to earn more that they didn’t have before, it’s all positive.
Andy-Lai :
This_Guy OP Amp : The positive far outweighs the negative but as you can see in the post there are some potential negative aspects to watch for long term.